If you're one of the millions of people dealing with psoriatic arthritis, you know just how frustrating it can be. One day, ...

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

We’ve known for some time that many chronic conditions are exacerbated by excess sodium intake. A new study links overuse of ...

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

Scalp psoriasis improvement was maintained with long-term tildrakizumab treatment in what researchers said is the first ...

Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

In this Healio exclusive video, Lawrence F. Eichenfield, MD, talks about takeaways in updates on topical treatments for ...

Immune checkpoint inhibitors for patients with cancer may be associated with an increased risk for psoriasis when compared ...

No new safety signals observed at Year 5 in the POETYK PSO long-term extension trial, consistent with the established Sotyktu ...

Bristol Myers Squibb (BMS) has shared positive five-year results from a long-term extension (LTE) study of its oral TYK2 ...